Takara Bio Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Takara Bio Inc (4974)
Takara Bio Inc stock price live, this page displays TYO 4974 stock exchange data. View the 4974 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Takara Bio Inc real time stock price chart below.
What Is the Takara Bio Inc Stock Price Today?
The Takara Bio Inc stock price today is 914.0.
What Is the Stock Symbol for Takara Bio Inc?
The stock symbol for Takara Bio Inc is ""4974.""
What Stock Exchange Does Takara Bio Inc Trade On?
Takara Bio Inc is listed and trades on the Tokyo stock exchange.
Is Takara Bio Inc a Good Stock to Buy?
Determining whether Takara Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4974 quote. (ISIN: JP3460200003)
What Is the Takara Bio Inc Stock Price Today?
The Takara Bio Inc stock price today is 914.0.
What Is the Stock Symbol for Takara Bio Inc?
The stock symbol for Takara Bio Inc is ""4974.""
What Stock Exchange Does Takara Bio Inc Trade On?
Takara Bio Inc is listed and trades on the Tokyo stock exchange.
Is Takara Bio Inc a Good Stock to Buy?
Determining whether Takara Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4974 quote. (ISIN: JP3460200003)
914.0
-3.0(-0.33%)
Closed·
Fair Value
An estimate of a Takara Bio's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
910.0
920.0
52 wk Range
711.0
1,141.0
4974 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected tomorrow
1/2
Fair Value
An estimate of a Takara Bio's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
910.0920.0
52 wk Range
711.01,141.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.85%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.85%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4974 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Takara Bio's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
1,170.0
Upside
+28.01%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
- Takara Bio Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Takara Bio Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Takara Bio Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Takara Bio Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Takara Bio Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Takara Bio Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Takara Bio Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Takara Bio Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Takara Bio Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Takara Bio Inc Company Profile
Takara Bio Inc., together with its subsidiaries, engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including reagents needed for genetic and cellular research, PCR instruments, cellular analysis devices, and in vitro diagnostics for COVID-19 testing. It also provides contract services related to regenerative medicine products and contract services related to gene analysis and testing. In addition, the company is involved in commercialization of its proprietary platform technology for biologics development; development, manufacture, and sale of manufacture ancillary materials, such as RetroNectin that is used in the manufacture of gene therapy product; application for marketing authorization of NY-ESO-1 siTCR gene therapy product; and development of JAK/STAT technology suitable for CAR gene therapy and applied development of CereAAV™, a brain-tropic adeno-associated virus vector. It provides its products and services through sales agents or directly to its customers. The company was incorporated in 2002 and is headquartered in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc.
Compare 4974 to Peers and Sector
Metrics to compare | 4974 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4974PeersSector | |
|---|---|---|---|---|
P/E Ratio | 105.6x | −6.8x | −0.5x | |
PEG Ratio | −3.58 | 0.00 | 0.00 | |
Price/Book | 1.0x | 4.5x | 2.6x | |
Price / LTM Sales | 2.4x | 40.9x | 3.3x | |
Upside (Analyst Target) | −9.5% | 58.4% | 43.5% | |
Fair Value Upside | Unlock | 12.0% | 6.9% | Unlock |
Analyst Ratings
1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 1,170.0
(+28.01% Upside)
Earnings
Latest Release
May 13, 2025
EPS / Forecast
20.10 / 21.40
Revenue / Forecast
15.76B / 15.96B
People Also Watch
FAQ
What Stock Exchange Does Takara Bio Trade On?
Takara Bio is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for Takara Bio?
The stock symbol for Takara Bio is "4974."
What Is the Takara Bio Market Cap?
As of today, Takara Bio market cap is 110.30B.
What Is Takara Bio's Earnings Per Share (TTM)?
The Takara Bio EPS (TTM) is 8.65.
When Is the Next Takara Bio Earnings Date?
Takara Bio will release its next earnings report on 07 Aug 2025.
From a Technical Analysis Perspective, Is 4974 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Takara Bio Stock Split?
Takara Bio has split 1 times.
How Many Employees Does Takara Bio Have?
Takara Bio has 1779 employees.
What is the current trading status of Takara Bio (4974)?
As of 07 Aug 2025, Takara Bio (4974) is trading at a price of 914.00, with a previous close of 917.00. The stock has fluctuated within a day range of 910.00 to 920.00, while its 52-week range spans from 711.00 to 1,141.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.